Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01ILA
|
|||
| Former ID |
DIB016179
|
|||
| Drug Name |
GNbAC-1
|
|||
| Synonyms |
GENHP-01; Anti-inflammatory (humanized mAbs, multiple sclerosis), GeNeuro SA; Anti-HERV-W (humanized monoclonal antibodies,multiple sclerosis), GeNeuro SA
Click to Show/Hide
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 2 | [1] | |
| Company |
GeNeuro SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01639300) Safety Study of GNbAC1 in Multiple Sclerosis Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.